Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$616M |
| 2 |
Netflix
NFLX
|
+$481M |
| 3 |
Micron Technology
MU
|
+$416M |
| 4 |
Tesla
TSLA
|
+$416M |
| 5 |
Procter & Gamble
PG
|
+$322M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$885M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$660M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$463M |
| 4 |
Applovin
APP
|
+$430M |
| 5 |
Meta Platforms (Facebook)
META
|
+$354M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.84% |
| 2 | Healthcare | 15.76% |
| 3 | Consumer Discretionary | 13.86% |
| 4 | Industrials | 9.95% |
| 5 | Financials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
British American Tobacco
BTI
$119B
| $3.01M | ﹤0.01% |
53,099
-274,000
| -84% | -$15M |
2025 Q1
3 quarters
|
|
1627
US Global Jets ETF
JETS
$815M
| $3.01M | ﹤0.01% |
+107,100
| New | +$2.78M |
2025 Q4
0 quarters
|
|
1628
Dingdong
DDL
$470M
| $3M | ﹤0.01% |
1,203,800
-411,709
| -25% | -$820K |
2022 Q4
12 quarters
|
|
1629
Allogene Therapeutics
ALLO
$504M
| $3M | ﹤0.01% |
2,187,084
-706,728
| -24% | -$932K |
2022 Q4
12 quarters
|
|
1630
Spero Therapeutics
SPRO
$69.9M
| $2.98M | ﹤0.01% |
1,279,522
-173,243
| -12% | -$402K |
2022 Q1
15 quarters
|
|
1631
Vital Farms
VITL
$401M
| $2.98M | ﹤0.01% |
93,229
-508,225
| -84% | -$17.9M |
2021 Q2
18 quarters
|
|
1632
iShares Russell 3000 ETF
IWV
$20.6B
| $2.97M | ﹤0.01% |
7,680
+1,380
| +22% | +$530K |
2023 Q2
10 quarters
|
|
1633
Via Transportation Inc
VIA
$2.64B
| $2.96M | ﹤0.01% |
+102,200
| New | +$4.22M |
2025 Q4
0 quarters
|
|
1634
Clearfield
CLFD
$462M
| $2.96M | ﹤0.01% |
101,700
+38,126
| +60% | +$1.23M |
2024 Q4
4 quarters
|
|
1635
KRONOS Worldwide
KRO
$876M
| $2.95M | ﹤0.01% |
668,397
-74,691
| -10% | -$363K |
2016 Q1
39 quarters
|
|
1636
Core Laboratories
CLB
$463M
| $2.94M | ﹤0.01% |
183,400
+149,219
| +437% | +$2.22M |
2025 Q3
1 quarter
|
|
1637
Paymentus
PAY
$4.01B
| $2.94M | ﹤0.01% |
+92,997
| New | +$3.03M |
2025 Q4
0 quarters
|
|
1638
South Plains Financial
SPFI
$797M
| $2.94M | ﹤0.01% |
75,700
-1,200
| -2% | -$45.9K |
2024 Q3
5 quarters
|
|
1639
Matrix Service
MTRX
$298M
| $2.93M | ﹤0.01% |
250,600
+6,000
| +2% | +$75.4K |
2022 Q2
14 quarters
|
|
1640
RF Industries
RFIL
$90.1M
| $2.93M | ﹤0.01% |
506,608
-2,000
| -0.4% | -$13.8K |
2013 Q2
50 quarters
|
|
1641
Lifestance Health
LFST
$4.72B
| $2.93M | ﹤0.01% |
415,900
-61,300
| -13% | -$370K |
2024 Q1
7 quarters
|
|
1642
Trustmark
TRMK
$2.57B
| $2.92M | ﹤0.01% |
74,862
-28,600
| -28% | -$1.11M |
2024 Q4
4 quarters
|
|
1643
Intellicheck
IDN
$46.2M
| $2.91M | ﹤0.01% |
436,365
+43,565
| +11% | +$246K |
2022 Q1
15 quarters
|
|
1644
Neighborhood Intelligence Inc
NXH
$186M
| $2.91M | ﹤0.01% |
+533,178
| New | +$3.87M |
2025 Q4
0 quarters
|
|
1645
Macy's
M
$5.92B
| $2.9M | ﹤0.01% |
131,664
-802,400
| -86% | -$16.4M |
2025 Q2
2 quarters
|
|
1646
Latham Group
SWIM
$711M
| $2.9M | ﹤0.01% |
456,400
-7,600
| -2% | -$53.2K |
2022 Q1
15 quarters
|
|
1647
PIMCO Active Bond Exchange-Traded Fund
BOND
$8.53B
| $2.89M | ﹤0.01% |
31,100
+27,200
| +697% | +$2.54M |
2025 Q1
3 quarters
|
|
1648
Corbus Pharmaceuticals
CRBP
$104M
| $2.88M | ﹤0.01% |
354,300
+247,100
| +231% | +$3.05M |
2024 Q3
5 quarters
|
|
1649
Strata Critical Medical Inc
SRTA
$401M
| $2.88M | ﹤0.01% |
598,786
+400
| +0.1% | +$1.94K |
2022 Q2
14 quarters
|
|
1650
iShares MSCI USA Quality Factor ETF
QUAL
$48.8B
| $2.88M | ﹤0.01% |
14,500
+9,900
| +215% | +$1.95M |
2025 Q3
1 quarter
|
|
Similar funds
Renaissance Technologies's Q4 2025 Portfolio in Review
As of Q4 2025, Renaissance Technologies held 3,923 positions worth $64.5B, down 15% from $75.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $10.1B in Q4 2025, closing 736 positions and reducing 1,682 holdings. Its most notable exit was Meta Platforms (Facebook), an estimated $354M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in ServiceNow worth $204M.
- Renaissance Technologies's largest Q4 2025 buy was ServiceNow: 1,331,977 shares worth $204M.
- Renaissance Technologies added most to Costco in Q4 2025, an estimated $616M increase.
- Renaissance Technologies's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $885M.
- Renaissance Technologies fully exited Meta Platforms (Facebook) in Q4 2025, selling an estimated $354M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.5B portfolio in Q4 2025.
- Renaissance Technologies opened 466 new positions and closed 736 in Q4 2025.
- Renaissance Technologies's portfolio value fell 15% quarter-over-quarter to $64.5B.
Based on Renaissance Technologies's 13F filing for Q4 2025, filed 12 Feb 2026.